Affinage

NOBOX

Homeobox protein NOBOX · UniProt O60393

Length
691 aa
Mass
73.9 kDa
Annotated
2026-06-10
39 papers in source corpus 18 papers cited in narrative 18 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 7/7 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

NOBOX is an oocyte-specific homeodomain transcription factor that drives the primordial-to-growing follicle transition by directly activating an oocyte gene expression program (PMID:16997917, PMID:17494914). It binds defined NOBOX binding elements (NBEs; core sequences TAATTG, TAGTTG, TAATTA) in target promoters and transactivates a set of oocyte-specific and pluripotency genes including Gdf9, Pou5f1/Oct4, Pad6, and KIT-L/KITLG (PMID:16997917, PMID:20659469, PMID:25514101). Genome-wide loss-of-function in mice establishes NOBOX as both an activator of oocyte-specific genes (Pou5f1, Sall4, Astl, Rspo2 among others) and a suppressor of the male-determining gene Dmrt1 (PMID:17494914); at the cellular level Nobox loss disrupts germ cell cyst breakdown and somatic cell invasion, producing syncytial rather than primordial follicles (PMID:21369782). In zebrafish, nobox is required for follicles to progress beyond the primary growth stage, and genetic epistasis places Nobox upstream of estrogen signaling, acting through aromatase (cyp19a1a) and Gdf9/Bmp15 to license vitellogenic growth (PMID:35157068, PMID:37990081). Beyond its ovarian role, NOBOX functions as an essential maternal transcription factor in bovine early embryogenesis, where its knockdown blocks blastocyst development and reduces pluripotency gene expression (PMID:21193554). NOBOX transcriptional output is tuned post-translationally by SUMO2/3 modification at K97, loss of which selectively elevates activity on the Gdf9 promoter (PMID:36607631). Human NOBOX mutations cause primary ovarian insufficiency: missense and truncating variants impair DNA binding, transactivation, nuclear localization, and protein stability, with a homeodomain mutation (p.Arg355His) acting dominant-negatively on wild-type DNA binding (PMID:17701902, PMID:21837770, PMID:27836978, PMID:27798098).

Mechanistic history

Synthesis pass · year-by-year structured walk · 15 steps
  1. 2006 High

    Established NOBOX as a sequence-specific DNA-binding transcription factor with defined recognition elements and direct target genes, converting it from a candidate oocyte factor into a defined transcriptional activator.

    Evidence CAST selection, EMSA, ChIP, and luciferase reporters defining NBEs and direct activation of Pou5f1 and Gdf9

    PMID:16997917

    Open questions at the time
    • Full target repertoire not defined
    • Co-activators/co-repressors at NBEs not identified
  2. 2007 High

    Showed that a disease homeodomain mutation abolishes NBE binding and acts dominant-negatively, linking NOBOX DNA-binding function directly to human ovarian disease mechanism.

    Evidence EMSA with the p.Arg355His mutant in human POI patients

    PMID:17701902

    Open questions at the time
    • Dominant-negative mechanism not tested in vivo
    • Effect on transcription of endogenous targets not shown
  3. 2007 Medium

    Defined the genome-wide consequences of Nobox loss, establishing it as an activator of oocyte genes and a suppressor of the male-determining gene Dmrt1.

    Evidence Affymetrix microarray and protein-binding microarray in Nobox knockout mouse ovary

    PMID:17494914

    Open questions at the time
    • Direct vs indirect targets not fully distinguished
    • Mechanism of Dmrt1 suppression unresolved
  4. 2011 Medium

    Defined the cellular phenotype of Nobox loss as failed cyst breakdown and somatic invasion, connecting transcriptional activity to follicle architecture.

    Evidence Electron microscopy of Nobox knockout mouse ovaries

    PMID:21369782

    Open questions at the time
    • Target genes mediating cyst breakdown not identified
    • Adherens junction link to NOBOX targets unestablished
  5. 2010 Medium

    Expanded the direct target set to Pad6 and established NOBOX as a maternal transcription factor required for early embryogenesis beyond the ovary.

    Evidence EMSA and reporter assays for Pad6; siRNA knockdown with blastocyst assays in bovine embryos

    PMID:20659469 PMID:21193554

    Open questions at the time
    • Maternal vs zygotic contribution not separated
    • Embryonic targets only partially defined
  6. 2011 Medium

    Identified post-transcriptional control of NOBOX by miR-196a and refined haploinsufficiency as the mechanism for POI-associated alleles.

    Evidence Luciferase 3'UTR reporter with MRE mutagenesis and in-embryo miRNA expression; transactivation assays of five POI missense/nonsense alleles on GDF9

    PMID:21548929 PMID:21837770

    Open questions at the time
    • miR-196a regulation shown in bovine only
    • Allele-specific quantitative contribution to haploinsufficiency unresolved
  7. 2012 Medium

    Mapped a functional distal NBE in the GDF9 promoter, confirming NBE-dependent transactivation in a native oocyte context.

    Evidence Promoter deletion and NBE mutagenesis with dual reporters in buffalo oocytes

    PMID:23078866

    Open questions at the time
    • Endogenous occupancy not confirmed by ChIP
    • Proximal vs distal NBE cooperation not addressed
  8. 2014 Medium

    Added KIT-L/KITLG to the direct NOBOX target set and tied POI mutations to reduced KIT-L transactivation, connecting NOBOX to somatic-germ cell signaling ligands.

    Evidence Luciferase reporter assays with patient-derived NOBOX variants

    PMID:25514101

    Open questions at the time
    • Direct binding to KIT-L promoter not confirmed by ChIP/EMSA
    • In vivo relevance not shown
  9. 2015 Medium

    Demonstrated isoform-specific transcriptional regulation of GDF9 during human oogenesis, refining which NOBOX transcript carries activity.

    Evidence Isoform cloning from human fetal ovary with GDF9 reporter assays

    PMID:25790371

    Open questions at the time
    • Relative abundance/role of isoforms in vivo unclear
    • Structural basis of isoform activity not defined
  10. 2016 Medium

    Characterized the loss-of-function spectrum of human NOBOX variants, revealing multiple convergent defects (transactivation, nuclear localization, stability, autophagic degradation, cell-cycle arrest) and confirming the single functional fetal-ovary isoform.

    Evidence Reporter, qRT-PCR, cell-cycle, immunolocalization, Western blot across multiple POI alleles and a homozygous truncating variant

    PMID:27798098 PMID:27836978

    Open questions at the time
    • FOXL2 interaction functional consequence not resolved
    • Aggregate formation mechanism unknown
  11. 2017 Low

    Proposed RSPO2 as an additional direct NOBOX target via an NBE-containing promoter.

    Evidence Promoter cloning and luciferase reporter assay

    PMID:28743298

    Open questions at the time
    • Single reporter assay with no ChIP or binding confirmation
    • In vivo dependence not tested
  12. 2019 Medium

    Provided in vivo transgenic evidence that an NBE drives oocyte-specific transcription, generalizing NOBOX-NBE regulation to a vertebrate ovarian gene.

    Evidence Transgenic reporter and promoter deletion analysis of hb4 in Xenopus

    PMID:31250783

    Open questions at the time
    • Endogenous hb4 regulation not assayed in knockouts
    • Conservation of mechanism in mammals not directly shown
  13. 2022 Medium

    Defined the developmental requirement for nobox after follicle assembly, showing arrest at primary growth stage and an all-male phenotype.

    Evidence CRISPR/Cas9 knockout and histology in zebrafish

    PMID:35157068

    Open questions at the time
    • Molecular targets mediating arrest not identified
    • Sex-reversal mechanism not resolved
  14. 2023 Medium

    Placed Nobox upstream of estrogen signaling in folliculogenesis via genetic epistasis, showing failure of vitellogenic growth rescuable by exogenous E2.

    Evidence nobox-/-;dmrt1-/- double mutants with qRT-PCR, serum estradiol, and E2 rescue in zebrafish

    PMID:37990081

    Open questions at the time
    • Direct regulation of cyp19a1a vs via Gdf9/Bmp15 not distinguished
    • Mammalian conservation of this axis untested
  15. 2023 Medium

    Identified SUMO2/3 modification at K97 as a post-translational regulator that selectively tunes NOBOX transcriptional output on the Gdf9 promoter.

    Evidence Site-directed mutagenesis (K97R, K125R), sumoylation assay, and luciferase reporters

    PMID:36607631

    Open questions at the time
    • SUMO E3 ligase and timing in vivo unknown
    • Promoter selectivity mechanism for Gdf9 vs Pou5f1 unexplained

Open questions

Synthesis pass · forward-looking unresolved questions
  • How NOBOX integrates co-factor binding (e.g. FOXL2), SUMO modification, and isoform selection to achieve promoter-specific target selection in vivo remains unresolved.
  • No structural model of NOBOX-NBE or NOBOX-cofactor complexes
  • Direct in vivo occupancy across the full target set not mapped
  • Mechanism coordinating Dmrt1 suppression with oocyte gene activation unknown

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0140110 transcription regulator activity 6 GO:0003677 DNA binding 3
Localization
GO:0005634 nucleus 1
Pathway
R-HSA-1474165 Reproduction 3 R-HSA-74160 Gene expression (Transcription) 3 R-HSA-1266738 Developmental Biology 2
Partners
FOXL2

Evidence

Reading pass · 18 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2006 NOBOX binds specific DNA sequences (TAATTG, TAGTTG, TAATTA) identified as NOBOX binding elements (NBEs) using cyclic amplification of sequence target (CAST) assay and mutation analyses, and directly activates transcription of Pou5f1 and Gdf9 by binding NBEs in their promoters, confirmed by chromatin immunoprecipitation and luciferase reporter assays. CAST assay, EMSA, chromatin immunoprecipitation (ChIP), luciferase reporter assay, mutational analysis The Journal of biological chemistry High 16997917
2007 The NOBOX homeodomain missense mutation p.Arg355His disrupts NOBOX binding to the NOBOX DNA-binding element (NBE) and exerts a dominant negative effect on wild-type NOBOX DNA binding, as demonstrated by electrophoretic mobility shift assay (EMSA). EMSA, Sanger sequencing, mutagenesis American journal of human genetics High 17701902
2007 Nobox deficiency in mice leads to downregulation of oocyte-specific genes (including Pou5f1/Oct4, Sall4, Astl, Jag1, Oosp1, Fetub, Rspo2) and upregulation of the male-determining gene Dmrt1, with protein-binding microarray identifying NBE motifs in the promoters of downregulated genes, indicating Nobox functions as an activator of oocyte-specific gene expression and suppressor of male-determining gene expression. Microarray (Affymetrix), protein-binding microarray, Nobox knockout mouse model Biology of reproduction Medium 17494914
2011 Five NOBOX missense mutations (p.G91W, p.R117W, p.S342T, p.V350L, and p.R303X nonsense) reduce the ability of NOBOX protein to bind to and transactivate the GDF9 promoter in transfected cells, consistent with haploinsufficiency as the mechanism underlying POI. Luciferase reporter assay, transfection, functional transactivation assay Human mutation Medium 21837770
2011 Loss of Nobox in mice causes defects in germ cell cyst breakdown and failure of somatic cell invasion, resulting in formation of syncytial follicles instead of primordial follicles, with abnormal adherens junctions between unseparated oocytes indicating faulty somatic-germ cell communication. Electron microscopy (ultrastructural analysis), Nobox knockout mouse model Journal of assisted reproduction and genetics Medium 21369782
2010 NOBOX directly binds an NBE (core sequence TAATTA) in the Pad6 (peptidylarginine deiminase 6) promoter and activates Pad6 transcription, establishing Pad6 as a direct transcriptional target of NOBOX in oocytes. EMSA, luciferase reporter assay, Nobox knockout mouse ovary expression analysis FEBS letters Medium 20659469
2010 NOBOX is an essential maternal-derived transcription factor in bovine early embryogenesis; siRNA-mediated knockdown of NOBOX in bovine embryos blocked development to the blastocyst stage, downregulated genes involved in transcriptional regulation, signal transduction, and cell cycle, and reduced pluripotency gene expression (POU5F1/OCT4 and NANOG) and inner cell mass cell number. siRNA knockdown, RT-PCR, immunofluorescence, blastocyst development assay Endocrinology Medium 21193554
2011 miR-196a directly targets the 3' UTR of bovine NOBOX mRNA to repress NOBOX protein expression; a miR-196a binding site was identified by algorithm, validated by luciferase reporter assay (suppressed by miR-196a, rescued by site-directed mutation of MRE), and ectopic miR-196a in bovine embryos reduced NOBOX at both mRNA and protein levels. Luciferase reporter assay, site-directed mutagenesis, ectopic miRNA expression in embryos, Western blot BMC developmental biology Medium 21548929
2014 NOBOX directly transactivates the KIT-L (KITLG/stem cell factor) promoter, identifying KIT-L as a novel direct transcriptional target of NOBOX, confirmed by luciferase reporter assay with POI-associated NOBOX mutations showing reduced KIT-L transactivation. Luciferase reporter assay, mutational analysis in patient-derived variants The Journal of clinical endocrinology and metabolism Medium 25514101
2015 A novel NOBOX isoform identified in human fetal ovary (distinct from the canonical transcript) is capable of upregulating the GDF9 promoter in reporter assays, demonstrating that isoform-specific transcriptional regulation of GDF9 by NOBOX occurs during human oogenesis. qRT-PCR, luciferase reporter assay, NOBOX isoform cloning from human fetal ovary PloS one Medium 25790371
2016 A homozygous NOBOX truncating variant (chr7:144098161delC) causes severe loss-of-function: the truncated NOBOX protein fails to transactivate the GDF9 promoter, reduces expression of multiple oocyte-related genes, and loses the ability to induce G2/M cell-cycle arrest; the 1725 bp NOBOX transcript expressed in human fetal ovary was confirmed as the only functional isoform in transcriptional activation assays. Luciferase reporter assay, qRT-PCR, cell cycle analysis, whole exome sequencing, isoform functional comparison Human reproduction (Oxford, England) Medium 27836978
2016 Multiple NOBOX variants associated with POI (p.R44L, p.G91W, p.G111R, p.G152R, p.K273*, p.R449*, p.D452N) exhibit variable functional defects including impaired transcriptional activity, autophagosomal protein degradation, defective nuclear localization, and protein instability; several variants retain the ability to interact with FOXL2 and form intracellular aggregates. Immunolocalization, Western blot, transcriptional assays, co-localization in HEK293T and CHO cells Human molecular genetics Medium 27798098
2017 RSPO2 is a direct transcriptional target of NOBOX: the RSPO2 promoter contains a NOBOX binding element (NBE), and NOBOX activates RSPO2 promoter-driven transcription in reporter assays. Promoter cloning, luciferase reporter assay, NBE identification Journal of ovarian research Low 28743298
2019 In Xenopus, a Nobox-binding element (NBE) in the proximal promoter of the hb4 gene is essential for its transcriptional activation specifically in oocytes, and Nobox expressed in the ovary drives hb4 transcription through this NBE, demonstrated by deletion analysis and luciferase reporter assays in transgenic frogs. Transgenic reporter analysis, promoter deletion constructs, luciferase reporter assay Zygote (Cambridge, England) Medium 31250783
2022 Loss of nobox in zebrafish (CRISPR/Cas9 knockout) prevents follicles from developing beyond the primary growth (perinucleolar) stage, resulting in all-male phenotype; follicle assembly from cystic oocytes occurs but follicles fail to progress to functional ovaries, indicating Nobox is required for follicle development after initial assembly. CRISPR/Cas9 knockout, histological analysis, zebrafish model Biology of reproduction Medium 35157068
2023 In zebrafish nobox-/-;dmrt1-/- double mutants, follicles form and progress to previtellogenic (PV) stage but fail to enter vitellogenic growth due to a deficiency in estrogen signaling, evidenced by reduced ovarian aromatase (cyp19a1a) expression, decreased serum estradiol, regressed female secondary sex characteristics, and rescue of vitellogenic growth by exogenous E2 treatment; Nobox may regulate cyp19a1a via control of Gdf9 and/or Bmp15. Genetic epistasis (nobox-/-;dmrt1-/- double mutant), qRT-PCR, serum hormone measurement, E2 rescue experiment, zebrafish model Communications biology Medium 37990081
2023 Mouse NOBOX is sumoylated by SUMO2/3 at a non-consensus site (K97); loss of NOBOX sumoylation at K97 (K97R mutation) increases transcriptional activity on the Gdf9 promoter but has no effect on the Pou5f1 promoter; K97R/K125R double mutants show altered higher molecular weight SUMO modifications, suggesting cooperation between these lysines in regulating NOBOX transcriptional output. Site-directed mutagenesis, sumoylation assay, luciferase reporter assay, Western blot FASEB journal Medium 36607631
2012 A distal NOBOX binding element (NBE) at -1.8 kb upstream of the TSS in the buffalo GDF9 promoter enhances GDF9 promoter activity in buffalo oocytes; site-directed mutation of the core NBE nucleotides abolished this enhancement, confirming the NBE is required for NOBOX-mediated transcriptional activation of GDF9. Promoter deletion constructs, luciferase reporter assay, GFP reporter, site-directed mutagenesis, oocyte transfection Animal reproduction science Medium 23078866

Source papers

Stage 0 corpus · 39 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2007 NOBOX homeobox mutation causes premature ovarian failure. American journal of human genetics 187 17701902
2002 Nobox is a homeobox-encoding gene preferentially expressed in primordial and growing oocytes. Mechanisms of development 131 11804785
2007 Microarray analyses of newborn mouse ovaries lacking Nobox. Biology of reproduction 109 17494914
2011 Novel NOBOX loss-of-function mutations account for 6.2% of cases in a large primary ovarian insufficiency cohort. Human mutation 77 21837770
2006 Characterization of NOBOX DNA binding specificity and its regulation of Gdf9 and Pou5f1 promoters. The Journal of biological chemistry 75 16997917
2011 Premature ovarian failure in nobox-deficient mice is caused by defects in somatic cell invasion and germ cell cyst breakdown. Journal of assisted reproduction and genetics 63 21369782
2011 MicroRNA-196a regulates bovine newborn ovary homeobox gene (NOBOX) expression during early embryogenesis. BMC developmental biology 61 21548929
2006 cDNA cloning and expression of the human NOBOX gene in oocytes and ovarian follicles. Molecular human reproduction 55 16597639
2016 A homozygous NOBOX truncating variant causes defective transcriptional activation and leads to primary ovarian insufficiency. Human reproduction (Oxford, England) 50 27836978
2008 Mutation analysis of NOBOX homeodomain in Chinese women with premature ovarian failure. Fertility and sterility 47 18930203
2014 New NOBOX mutations identified in a large cohort of women with primary ovarian insufficiency decrease KIT-L expression. The Journal of clinical endocrinology and metabolism 43 25514101
2010 A novel functional role for the oocyte-specific transcription factor newborn ovary homeobox (NOBOX) during early embryonic development in cattle. Endocrinology 43 21193554
2015 GDF9 is transiently expressed in oocytes before follicle formation in the human fetal ovary and is regulated by a novel NOBOX transcript. PloS one 39 25790371
2009 Oogenesis specific genes (Nobox, Oct4, Bmp15, Gdf9, Oogenesin1 and Oogenesin2) are differentially expressed during natural and gonadotropin-induced mouse follicular development. Molecular reproduction and development 36 19480014
2005 Mutational analysis of the homeobox region of the human NOBOX gene in Japanese women who exhibit premature ovarian failure. Fertility and sterility 33 15950662
2016 Impaired protein stability and nuclear localization of NOBOX variants associated with premature ovarian insufficiency. Human molecular genetics 23 27798098
2016 NOBOX is a strong autosomal candidate gene in Tunisian patients with primary ovarian insufficiency. Clinical genetics 22 26848058
2017 A novel homozygous 1-bp deletion in the NOBOX gene in two Brazilian sisters with primary ovarian failure. Endocrine 18 29067606
2013 Effects of thioredoxin: SUMO and intein on soluble fusion expression of an antimicrobial peptide OG2 in Escherichia coli. Protein and peptide letters 18 22670762
2013 The NOBOX protein becomes undetectable in developmentally competent antral and ovulated oocytes. The International journal of developmental biology 18 23585350
2022 Loss of Nobox prevents ovarian differentiation from juvenile ovaries in zebrafish. Biology of reproduction 17 35157068
2010 The oocyte-specific transcription factor, Nobox, regulates the expression of Pad6, a peptidylarginine deiminase in the oocyte. FEBS letters 16 20659469
2023 Genetic evidence for differential functions of figla and nobox in zebrafish ovarian differentiation and folliculogenesis. Communications biology 13 37990081
2001 Expression of mouse osteocalcin transcripts, OG1 and OG2, is differently regulated in bone tissues and osteoblast cultures. Journal of bone and mineral metabolism 13 11685649
2013 High-yield soluble expression and simple purification of the antimicrobial peptide OG2 using the intein system in Escherichia coli. BioMed research international 12 23936842
2017 Biodegradation of α-endosulfan via hydrolysis pathway by Stenotrophomonas maltophilia OG2. 3 Biotech 10 28567625
2017 R-spondin2, a novel target of NOBOX: identification of variants in a cohort of women with primary ovarian insufficiency. Journal of ovarian research 9 28743298
2023 Sumoylation regulates functional properties of the oocyte transcription factors SOHLH1 and NOBOX. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 8 36607631
2023 NOBOX gene variants in premature ovarian insufficiency: ethnicity-dependent insights. Journal of assisted reproduction and genetics 8 37921973
2021 Compound heterozygous null mutations of NOBOX in sisters with delayed puberty and primary amenorrhea. Molecular genetics & genomic medicine 8 34480423
2022 Hypo-Hydroxymethylation of Nobox is Associated with Ovarian Dysfunction in Rat Offspring Exposed to Prenatal Hypoxia. Reproductive sciences (Thousand Oaks, Calif.) 5 35257353
2025 Reclassifying NOBOX variants in primary ovarian insufficiency cases with a corrected gene model and a novel quantitative framework. Human reproduction (Oxford, England) 4 40246288
2012 A reporter promoter assay confirmed the role of a distal promoter NOBOX binding element in enhancing expression of GDF9 gene in buffalo oocytes. Animal reproduction science 4 23078866
2011 Establishment of novel embryonic stem (ES) cell lines from OG2/rtTA blastocysts. Journal of genetics and genomics = Yi chuan xue bao 3 21777853
2024 Association between polymorphisms in NOBOX and litter size traits in Xiangsu pigs. Frontiers in veterinary science 2 38523712
2009 Cloning and characterization of porcine NOBOX gene. Sheng wu gong cheng xue bao = Chinese journal of biotechnology 2 19938448
2026 Deletion of the glucocorticoid receptor in osteoblasts and osteocytes drives trabecular bone loss in Col2.3-Cre and OG2-Cre knockout mice. Bone 0 41903788
2025 Primary ovarian insufficiency due to homozygous variants in the homeobox transcription factor NOBOX. Molecular biology reports 0 41324758
2019 Specific activation of the hb4 gene in the Xenopus oocyte through a Nobox-binding element located at the proximal promoter sequence. Zygote (Cambridge, England) 0 31250783

Missed literature

Know a paper Affinage missed for NOBOX? Flag it for the maintainers and the community.

No submissions yet.